Clinical trial
Precision Study on "Cocktail" Therapy to Improve the Efficacy of Hepatitis B-related Hepatocellular Carcinoma
NCT04317248 is registered in ClinicalTrials.gov with Yuehua Huang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Study on "Cocktail" Therapy to Improve the Efficacy of Hepatitis B-related Hepatocellular Carcinoma
- Lead sponsor
- Yuehua Huang
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- April 30, 2022
- Enrollment
- 600 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma